Literature DB >> 22674145

Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model.

Shelby D Reed, Gary H Lyman.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22674145     DOI： 10.1002/cncr.27665

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  2 in total

1.  Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection.

Authors:  Alexandre Loupy; Carmen Lefaucheur; Dewi Vernerey; Jessica Chang; Luis G Hidalgo; Thibaut Beuscart; Jerome Verine; Olivier Aubert; Sébastien Dubleumortier; Jean-Paul Duong van Huyen; Xavier Jouven; Denis Glotz; Christophe Legendre; Philip F Halloran
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

Review 2.  Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses.

Authors:  Roman Rouzier; Paolo Pronzato; Elisabeth Chéreau; Josh Carlson; Barnaby Hunt; William J Valentine
Journal:  Breast Cancer Res Treat       Date:  2013-05-31       Impact factor: 4.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.